-
1
-
-
0028304289
-
Intravenous gammaglobulin: Pharmacology, clinical uses and mechanisms of action
-
Schiff RI. Intravenous gammaglobulin: Pharmacology, clinical uses and mechanisms of action. Pediatr Allergy Immunol 1994; 5: 63-87.
-
(1994)
Pediatr. Allergy Immunol.
, vol.5
, pp. 63-87
-
-
Schiff, R.I.1
-
2
-
-
0023674879
-
Human gamma globulins as therapeutic agents
-
Stiehm ER. Human gamma globulins as therapeutic agents. Adv Pediatr 1988; 35: 1-72.
-
(1988)
Adv. Pediatr.
, vol.35
, pp. 1-72
-
-
Stiehm, E.R.1
-
3
-
-
33947444499
-
Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids
-
Cohn EJ, Strong LE, Hughes WL Jr, et al. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc 1946; 68: 459-475.
-
(1946)
J. Am. Chem. Soc.
, vol.68
, pp. 459-475
-
-
Cohn, E.J.1
Strong, L.E.2
Hughes Jr., W.L.3
-
5
-
-
0000635717
-
Large scale production of human plasma fractions: Eight years of experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier
-
Kistler P, Nitschmann H. Large scale production of human plasma fractions: Eight years of experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier. Vox Sang 1962; 7: 414-424.
-
(1962)
Vox. Sang.
, vol.7
, pp. 414-424
-
-
Kistler, P.1
Nitschmann, H.2
-
6
-
-
0022540377
-
Development of immunoglobulin preparations for intravenous use
-
Barandun S, Isliker H. Development of immunoglobulin preparations for intravenous use. Vox Sang 1986; 51: 157-160.
-
(1986)
Vox. Sang.
, vol.51
, pp. 157-160
-
-
Barandun, S.1
Isliker, H.2
-
7
-
-
0000419304
-
Agammaglobulinemia
-
Bruton OC. Agammaglobulinemia. Pediatrics 1952; 9: 722-727.
-
(1952)
Pediatrics
, vol.9
, pp. 722-727
-
-
Bruton, O.C.1
-
8
-
-
19044377860
-
Intravenous immunoglobulins: Clinical experience and viral safety
-
Ballow M. Intravenous immunoglobulins: Clinical experience and viral safety. J Am Pharm Assoc 2002; 42: 449-458.
-
(2002)
J. Am. Pharm. Assoc.
, vol.42
, pp. 449-458
-
-
Ballow, M.1
-
9
-
-
0026422422
-
The use of intravenous immune globulin in immunodeficiency diseases
-
Buckley RH, Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 1991; 325: 110-117.
-
(1991)
N. Engl. J. Med.
, vol.325
, pp. 110-117
-
-
Buckley, R.H.1
Schiff, R.I.2
-
10
-
-
0034775263
-
Intravenous immunoglobulin consensus statement
-
and the IVIG Advisory Panel III. Consensus reporT
-
Sacher RA, and the IVIG Advisory Panel III. Consensus reporT. Intravenous immunoglobulin consensus statement. J Allergy Clin Immunol 2001; 108: S139-S146.
-
(2001)
J. Allergy Clin. Immunol.
, vol.108
-
-
Sacher, R.A.1
-
11
-
-
0027102912
-
Established and new uses of intravenous immunoglobulin
-
Cunningham-Runddles C. Established and new uses of intravenous immunoglobulin. Mt Sinai J Med 1992; 59: 335-340.
-
(1992)
Mt. Sinai J. Med.
, vol.59
, pp. 335-340
-
-
Cunningham-Runddles, C.1
-
12
-
-
0036221826
-
Intravenous immunoglobulin in neurological disease: A specialist review
-
Wiles CM, Brown P, Chapel H, et al. Intravenous immunoglobulin in neurological disease: A specialist review. J Neurol Neurosurg Psychiatry 2002; 72: 440-448.
-
(2002)
J. Neurol. Neurosurg. Psychiatry
, vol.72
, pp. 440-448
-
-
Wiles, C.M.1
Brown, P.2
Chapel, H.3
-
13
-
-
2442583225
-
Toxic epidermal necrolysis - Intravenous immunoglobulin. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: Multicenter retrospective analysis of 48 consecutive cases
-
for the TEN IVIG Study Group
-
Prins C, Kerdel FA, Padilla RS, et al., for the TEN IVIG Study Group. Toxic epidermal necrolysis - intravenous immunoglobulin. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: Multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003; 139: 26-32
-
(2003)
Arch. Dermatol.
, vol.139
, pp. 26-32
-
-
Prins, C.1
Kerdel, F.A.2
Padilla, R.S.3
-
14
-
-
0036715291
-
Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris
-
Sami N, Qureshi A, Ruocco E, Ahmed AR. Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris. Arch Dermatol 2002; 138: 1158-1162.
-
(2002)
Arch. Dermatol.
, vol.138
, pp. 1158-1162
-
-
Sami, N.1
Qureshi, A.2
Ruocco, E.3
Ahmed, A.R.4
-
15
-
-
0035185417
-
Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment
-
Ahmed AR. Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 2001; 45: 825-835
-
(2001)
J. Am. Acad. Dermatol.
, vol.45
, pp. 825-835
-
-
Ahmed, A.R.1
-
16
-
-
0035064094
-
A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders
-
Jolles S. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders. Clin Exp Dermatol 2001; 26: 127-131.
-
(2001)
Clin. Exp. Dermatol.
, vol.26
, pp. 127-131
-
-
Jolles, S.1
-
17
-
-
0036113782
-
The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases
-
Pyne D, Ehrenstein M, Morris V. The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases. Rheumatology 2002; 41: 367-374.
-
(2002)
Rheumatology
, vol.41
, pp. 367-374
-
-
Pyne, D.1
Ehrenstein, M.2
Morris, V.3
-
18
-
-
0036286074
-
Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency
-
Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109: 1001-1004.
-
(2002)
J. Allergy Clin. Immunol.
, vol.109
, pp. 1001-1004
-
-
Busse, P.J.1
Razvi, S.2
Cunningham-Rundles, C.3
-
19
-
-
0034769492
-
Antibody-directed therapy: Past, present, and future
-
Gelfand EW. Antibody-directed therapy: Past, present, and future. J Allergy Clin Immunol 2001; 108: S111-S116.
-
(2001)
J. Allergy Clin. Immunol.
, vol.108
-
-
Gelfand, E.W.1
-
20
-
-
0028857579
-
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs
-
Gardulf A, Andersen V, Bjorkander J, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs. Lancet 1995; 345: 365-369.
-
(1995)
Lancet
, vol.345
, pp. 365-369
-
-
Gardulf, A.1
Andersen, V.2
Bjorkander, J.3
-
21
-
-
0018825013
-
Immunoglobulin replacement therapy by slow subcutaneous infusion
-
Berger M, Cupps TR, Fauci AS. Immunoglobulin replacement therapy by slow subcutaneous infusion. Ann Intern Med 1980; 93: 55-56.
-
(1980)
Ann. Intern. Med.
, vol.93
, pp. 55-56
-
-
Berger, M.1
Cupps, T.R.2
Fauci, A.S.3
-
22
-
-
0020960844
-
Slow subcutaneous immunoglobulin therapy in a patient with reactions to intramuscular immunoglobulin
-
Welch MJ, Stiehm ER. Slow subcutaneous immunoglobulin therapy in a patient with reactions to intramuscular immunoglobulin. J Clin Immunol 1983; 3: 285-286.
-
(1983)
J. Clin. Immunol.
, vol.3
, pp. 285-286
-
-
Welch, M.J.1
Stiehm, E.R.2
-
23
-
-
0020055647
-
High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy
-
Berger M, Cupps TR, Fauci AS. High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy. J Am Med Assoc 1982; 247: 2824-2825
-
(1982)
J. Am. Med. Assoc.
, vol.247
, pp. 2824-2825
-
-
Berger, M.1
Cupps, T.R.2
Fauci, A.S.3
-
24
-
-
0022648987
-
Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia
-
(letter)
-
Leahy MF. Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia (letter). Lancet 1986; 2: 48.
-
(1986)
Lancet
, vol.2
, pp. 48
-
-
Leahy, M.F.1
-
25
-
-
0025738608
-
Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion
-
Gardulf A, Hammarstrom L, Smith CI. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet 1991; 338: 162-166.
-
(1991)
Lancet
, vol.338
, pp. 162-166
-
-
Gardulf, A.1
Hammarstrom, L.2
Smith, C.I.3
-
26
-
-
0027180544
-
The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions
-
Gardulf A, Bjorvell H, Gustafson R, et al. The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions. Clin Exp Immunol 1993; 92: 200-204.
-
(1993)
Clin. Exp. Immunol.
, vol.92
, pp. 200-204
-
-
Gardulf, A.1
Bjorvell, H.2
Gustafson, R.3
-
27
-
-
0027724615
-
Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency
-
Gardulf A, Bjorvell H, Gustafson R, et al. Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency. Immunodeficiency 1993; 4: 81-84.
-
(1993)
Immunodeficiency
, vol.4
, pp. 81-84
-
-
Gardulf, A.1
Bjorvell, H.2
Gustafson, R.3
-
28
-
-
0029908505
-
Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies
-
Abrahamsen TG, Sandersen H, Bustnes A. Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies. Pediatrics 1996; 98: 1127-1131.
-
(1996)
Pediatrics
, vol.98
, pp. 1127-1131
-
-
Abrahamsen, T.G.1
Sandersen, H.2
Bustnes, A.3
-
29
-
-
0034073949
-
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
-
Chapel HM, Spickett GP, Ericson D, et al. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol 2000; 20: 94-100.
-
(2000)
J. Clin. Immunol.
, vol.20
, pp. 94-100
-
-
Chapel, H.M.1
Spickett, G.P.2
Ericson, D.3
-
30
-
-
0036281312
-
Novel aspects of hypogammaglobulinemic states: Subcutaneous immunoglobulin treatment
-
Grunebaum E, Levy Y, Shoenfeld Y. Novel aspects of hypogammaglobulinemic states: Subcutaneous immunoglobulin treatment. Isr Med Assoc J 2002; 4: 288-289.
-
(2002)
Isr. Med. Assoc. J.
, vol.4
, pp. 288-289
-
-
Grunebaum, E.1
Levy, Y.2
Shoenfeld, Y.3
-
31
-
-
0031802363
-
Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy
-
Sundin U, Nava S, Hammarstrom L. Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy. Clin Exp Immunol 1998; 112: 341-346.
-
(1998)
Clin. Exp. Immunol.
, vol.112
, pp. 341-346
-
-
Sundin, U.1
Nava, S.2
Hammarstrom, L.3
-
32
-
-
0031871760
-
Immunoglobulin replacement treatment by rapid subcutaneous infusion
-
Gaspar J, Gerritsen B, Jones A. Immunoglobulin replacement treatment by rapid subcutaneous infusion. Arch Dis Child 1998; 79: 48-51.
-
(1998)
Arch. Dis. Child.
, vol.79
, pp. 48-51
-
-
Gaspar, J.1
Gerritsen, B.2
Jones, A.3
-
33
-
-
0033982566
-
Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: Case report and literature review of intravenous immunoglobulin-related thrombotic complications
-
Go RS, Call TG. Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: Case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin Proc 2000; 75: 83-85.
-
(2000)
Mayo Clin. Proc.
, vol.75
, pp. 83-85
-
-
Go, R.S.1
Call, T.G.2
-
34
-
-
0021259298
-
Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases
-
Ochs HD, Fischer SH, Wedgwood RJ, et al. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Am J Med 1984; 76: 78-82.
-
(1984)
Am. J. Med.
, vol.76
, pp. 78-82
-
-
Ochs, H.D.1
Fischer, S.H.2
Wedgwood, R.J.3
-
35
-
-
0035822661
-
The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia: A randomized, double-blind, multicenter crossover trial
-
for the Inter-University Working Party for the Study of Immune Deficiencies
-
Eijkhout HW, van der Meer JWM, Kallenberg CGM, et al., for the Inter-University Working Party for the Study of Immune Deficiencies. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia: A randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001; 135: 165-174.
-
(2001)
Ann. Intern. Med.
, vol.135
, pp. 165-174
-
-
Eijkhout, H.W.1
van der Meer, J.W.M.2
Kallenberg, C.G.M.3
|